サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
941357

核酸分離・精製の世界市場：製品 (キット・試薬・装置)、手法（カラム・磁性ビーズ)、タイプ (ゲノムDNA・プラスミドDNA・miRNA)、用途 (創薬・精密医療) - 2025年までの予測

Nucleic Acid Isolation & Purification Market by Product (Kit, Reagent, Instrument), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA, miRNA), Application (Drug Discovery, Precision Medicine), End User (Academic)-Global Forecast to 2025
出版日: | 発行: MarketsandMarkets | ページ情報: 英文 192 Pages | 納期: 即納可能 即納可能とは
AI翻訳ツール 提供対象
ご購入後の翻訳ツール提供について
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=137.14円
核酸分離・精製の世界市場：製品 (キット・試薬・装置)、手法（カラム・磁性ビーズ)、タイプ (ゲノムDNA・プラスミドDNA・miRNA)、用途 (創薬・精密医療) - 2025年までの予測
出版日: 2020年06月03日
発行: MarketsandMarkets
ページ情報: 英文 192 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要
CAGR 8.9%

世界の核酸分離・精製市場規模は、2020年の32億米ドルから、2025年までに48億米ドルに達すると予測され、予測期間中のCAGRは8.9%が見込まれています。同市場の成長を促進する主な要因は、R&D活動の増加、技術進歩、および自動化の拡大です。しかし、自動化装置の高コスト性は、市場の成長を妨げると予測されています。タイプ別では、プラスミドDNAセグメントが、2019年に最大のシェアを構成しました。これは、PCR、シーケンシング、タンパク質発現、遺伝子治療、およびトランスフェクションといった、様々な下流用途における精製プラスミドDNAの広範な利用に起因しています。地域別では、北米が2019年の市場で最大のシェアを構成しました。バイオテクノロジー・医薬品企業における研究開発への多額の投資、バイオテクノロジー産業の大規模化、技術進歩、および地域における政府の支援が、この地域を牽引する主要な要因となっています。一方、アジア太平洋地域は、予測期間中に最も高い成長率を記録すると予測されています。

当レポートでは、世界の核酸分離・精製市場について調査し、市場の概要、製品、手法、タイプ、用途、エンドユーザー、および地域別による市場の分析と予測、競合情勢の分析、および主要企業のプロファイルなどを提供しています。

941357_4.3 GEOGRAPHICAL SNAPSHOT OF THE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET_FIGURE 16

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 核酸分離・精製市場の概要
  • 北米の核酸分離・精製市場：製品別
  • 核酸分離・精製市場の地域スナップショット

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
    • 動向

第6章 核酸分離・精製市場：製品別

  • イントロダクション
  • キット
  • 試薬
  • 装置

第7章 核酸分離・精製市場：手法別

  • イントロダクション
  • カラムベース
  • 磁気ビーズベース
  • 試薬ベース
  • その他

第8章 核酸分離・精製市場：タイプ別

  • イントロダクション
  • プラスミドDNA核酸分離・精製
  • トータルRNA核酸分離・精製
  • ゲノムDNA核酸分離・精製
  • mRNA核酸分離・精製
  • 循環核酸分離・精製
  • マイクロRNA核酸分離・精製
  • PCRクリーンアップ
  • その他

第9章 核酸分離・精製市場：用途別

  • イントロダクション
  • 診断
  • 創薬・開発
  • パーソナライズドメディスン
  • 農業・動物研究
  • その他の用途

第10章 核酸分離・精製市場：エンドユーザー別

  • イントロダクション
  • 病院・診断センター
  • 学術・政府系研究機関
  • 医薬品・バイオテクノロジー企業
  • CRO
  • その他のエンドユーザー

第11章 核酸分離・精製市場：地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • その他の欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • その他のアジア太平洋
  • その他の地域
    • ラテンアメリカ
    • 中東・アフリカ

第12章 競合情勢

  • イントロダクション
  • 市場評価フレームワーク
  • 主要な市場参入企業の収益分析
  • 競合シナリオ

第13章 企業評価マトリックス・企業プロファイル

  • 会社評価マトリックス
  • 競合リーダーシップマッピング

第14章 企業プロファイル

  • QIAGEN N.V.
  • THERMO FISHER SCIENTIFIC
  • F. HOFFMAN-LA ROCHE AG
  • PROMEGA CORPORATION
  • AGILENT TECHNOLOGIES
  • BIO-RAD LABORATORIES
  • DANAHER CORPORATION
  • GE HEALTHCARE
  • ILLUMINA
  • MERCK KGAA
  • タカラバイオ
  • NEW ENGLAND BIOLABS
  • ZYMO RESEARCH
  • NORGEN BIOTEK
  • OMEGA BIO-TEK, INC.
  • その他の会社
    • GENAXXON BIOSCIENCE GMBH
    • 3B BLACKBIO BIOTECH INDIA LTD。
    • INVITEK MOLECULAR GMBH
    • BIOVISION
    • ANALYTIK JENA AG

第15章 付録

図表

LIST OF TABLES

  • TABLE 1 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 2 NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 3 NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 4 NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 5 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2025 (USD MILLION)
  • TABLE 6 COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 7 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 8 REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 9 OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 10 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 11 PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 12 TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 13 GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 14 MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 15 CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 16 MICRORNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 17 PCR CLEANUP MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 18 OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 19 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 20 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 21 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 22 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 23 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 24 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 25 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 26 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 27 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 28 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 29 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 30 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER END USERS, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 31 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 32 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 33 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 34 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2025 (USD MILLION)
  • TABLE 35 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 36 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 37 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 38 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 39 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2025 (USD MILLION)
  • TABLE 40 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 41 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 42 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 43 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 44 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2025 (USD MILLION)
  • TABLE 45 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 46 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 47 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 48 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 49 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 50 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2025 (USD MILLION)
  • TABLE 51 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 52 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 53 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 54 CANCER INCIDENCE IN GERMANY, BY TYPE, 2018 VS. 2025
  • TABLE 55 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 56 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2025 (USD MILLION)
  • TABLE 57 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 58 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 59 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 60 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 61 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2025 (USD MILLION)
  • TABLE 62 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 63 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 64 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 65 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 66 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2025 (USD MILLION)
  • TABLE 67 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 68 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 69 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 70 ROE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 71 ROE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2025 (USD MILLION)
  • TABLE 72 ROE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 73 ROE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 74 ROE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 75 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 76 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 77 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2025 (USD MILLION)
  • TABLE 78 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 79 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 80 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 81 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 82 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2025 (USD MILLION)
  • TABLE 83 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 84 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 85 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 86 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 87 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2025 (USD MILLION)
  • TABLE 88 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 89 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 90 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 91 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 92 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2025 (USD MILLION)
  • TABLE 93 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 94 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 95 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 96 ROAPAC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 97 ROAPAC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2025 (USD MILLION)
  • TABLE 98 ROAPAC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 99 ROAPAC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 100 ROAPAC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 101 ROW: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 102 ROW: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 103 ROW: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2025 (USD MILLION)
  • TABLE 104 ROW: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 105 ROW: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 106 ROW: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 107 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 108 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2025 (USD MILLION)
  • TABLE 109 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 110 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 111 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 112 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 113 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2018-2025 (USD MILLION)
  • TABLE 114 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 115 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 116 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2018-2025 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1 RESEARCH DESIGN
  • FIGURE 2 PRIMARY SOURCES
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC
  • FIGURE 6 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET - CAGR PROJECTION
  • FIGURE 7 DATA TRIANGULATION METHODOLOGY
  • FIGURE 8 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
  • FIGURE 9 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2020 VS. 2025 (USD MILLION)
  • FIGURE 10 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
  • FIGURE 11 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
  • FIGURE 12 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
  • FIGURE 13 GEOGRAPHICAL SNAPSHOT OF THE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
  • FIGURE 14 TECHNOLOGICAL ADVANCEMENTS AND INCREASING AUTOMATION TO DRIVE MARKET GROWTH
  • FIGURE 15 KITS ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN NUCLEIC ACID ISOLATION AND PURIFICATION PRODUCTS MARKET IN 2019
  • FIGURE 16 ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH RATE IN THE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FROM 2020 TO 2025
  • FIGURE 17 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
  • FIGURE 18 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION
  • FIGURE 19 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SNAPSHOT
  • FIGURE 20 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SNAPSHOT
  • FIGURE 21 MARKET EVOLUTION FRAMEWORK (2017-2019)
  • FIGURE 22 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET IN 2019
  • FIGURE 23 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019
  • FIGURE 24 COMPETITIVE LEADERSHIP MAPPING (GLOBAL) NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, 2019
  • FIGURE 25 COMPANY SNAPSHOT: QIAGEN N.V. (2019)
  • FIGURE 26 COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC (2019)
  • FIGURE 27 COMPANY SNAPSHOT: F. HOFFMANN-LA ROCHE AG (2019)
  • FIGURE 28 COMPANY SNAPSHOT: AGILENT TECHNOLOGIES INC. (2019)
  • FIGURE 29 COMPANY SNAPSHOT: BIO-RAD LABORATORIES, INC. (2019)
  • FIGURE 30 COMPANY SNAPSHOT: DANAHER CORPORATION (2019)
  • FIGURE 31 COMPANY SNAPSHOT: GE HEALTHCARE (2019)
  • FIGURE 32 COMPANY SNAPSHOT: ILLUMINA, INC. (2019)
  • FIGURE 33 COMPANY SNAPSHOT: MERCK KGAA (2019)
  • FIGURE 34 COMPANY SNAPSHOT: TAKARA BIO (2019)
目次
Product Code: BT 2398

"The nucleic acid isolation and purification market is projected to grow at a CAGR of 8.9% during the forecast period (2020-2025)."

The global nucleic acid isolation and purification market is projected to reach USD 4.8 billion by 2025 from USD 3.2 billion in 2020, at a CAGR of 8.9% during the forecast period. The major factors driving the growth of the market include increasing R&D activities as well as technological advancements and increasing automation. However, the high cost of automated instruments is expected to hinder the growth of the market.

"The instruments segment will grow at the highest rate during the forecast period."

On the basis of product, the nucleic acid isolation and purification market is segmented into kits, reagents, and instruments. In 2019, kits were the largest product segment in the market. Growth in this market can be attributed to the continuous focus of key market players on developing and launching new and advanced kits. However, the instruments segment is expected to grow at the highest rate during the forecast period.

"By type, the plasmid DNA isolation and purification segment accounted for the largest share of the nucleic acid isolation and purification market in 2019."

On the basis of type, the global nucleic acid isolation and purification market is segmented into plasmid DNA isolation and purification, total RNA isolation and purification, circulating nucleic acid isolation and purification, genomic DNA isolation and purification, messenger RNA isolation and purification, microRNA isolation and purification, PCR cleanup, and other nucleic acid isolation and purification types. The plasmid DNA isolation segment accounted for the largest share of the nucleic acid isolation and purification market in 2019. The large share of this market segment can be attributed to the wide use of purified plasmid DNA in a variety of downstream applications, such as PCR, sequencing, expression of proteins, gene therapy, and transfection.

"The market in the Asia Pacific is projected to witness the highest growth rate during the forecast period (2020-2025)."

North America accounted for the largest share of the nucleic acid isolation and purification market in 2019. Significant R&D spending in biotechnology and pharmaceutical companies, the large size of the biotechnology industry, technological advancements, and government support in the region are the key factors driving the growth of the nucleic acid isolation and purification market in North America. On the other hand, the Asia Pacific is projected to register the highest growth during the forecast period. This large share can be attributed to factors such as the increasing number of genomic projects and increasing R&D investments by pharmaceutical & biotechnology companies in this region.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type (Supply-side): Tier 1 (29%), Tier 2 (37%), and Tier 3 (34%)
  • By Category (Demand-side): Pharmaceutical & Biotechnology Companies (38%), Hospitals & Diagnostic Centers (30%), and Academic & Government Research Institutes (22%), and Other End Users (10%)
  • By Designation: C-level (37%), Director-level (23%), and Managers (40%)
  • By Region: North America (37%), Europe (30%), Asia Pacific (21%), and the RoW (12%)

QIAGEN N.V. (Netherlands), Thermo Fisher Scientific (US), and F. Hoffmann-La Roche Ltd. (Switzerland) are the leading players in the global nucleic acid isolation and purification market. Other notable players in this market include Promega Corporation (US), Agilent Technologies (US), Bio-Rad Laboratories (US), Danaher Corporation (US), GE Healthcare (US), Illumina, Inc. (US), Merck KGaA (Germany), Takara Bio (Japan), Zymo Research (US), New England Biolabs (US), Norgen Biotek Corp (Canada), Omega Bio-tek (US), Genaxxon Bioscience GmbH (Germany), 3B BlackBio Biotech India Limited (India), Invitek Molecular (Germany), BioVision (US), and Analytik Jena AG (Germany).

Research Coverage:

The report analyzes the nucleic acid isolation and purification market and aims at estimating the market size and future growth potential of this market based on various segments such as product, method, type, application, end user, and region. The report also includes the competitive analysis of the key players in this market, along with their company profiles, product & service offerings, recent developments, and key market strategies.

Reasons to Buy the Report:

The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies.

This report provides insights into the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the nucleic acid isolation and purification market. The report analyzes the market based on the product, type, application, end user, and region.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the nucleic acid isolation and purification market.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of nucleic acid isolation and purification solutions across regions.
  • Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the nucleic acid isolation and purification market.
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the nucleic acid isolation and purification market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Breakdown of primary sources
  • 2.2 MARKET SIZE ESTIMATION
  • 2.3 MARKET GROWTH RATE PROJECTIONS
  • 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.5 MARKET SHARE ESTIMATION
  • 2.6 ASSUMPTIONS FOR THE STUDY
  • 2.7 LIMITATIONS FOR RESEARCH

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET OVERVIEW
  • 4.2 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT (2019)
  • 4.3 GEOGRAPHICAL SNAPSHOT OF THE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET

5 MARKET OVERVIEW

  • 5.1 MARKET DYNAMICS
    • 5.1.1 DRIVERS
      • 5.1.1.1 Increasing R&D activities
      • 5.1.1.2 Technological advancements and increasing automation
    • 5.1.2 RESTRAINTS
      • 5.1.2.1 High cost of automated instruments
    • 5.1.3 OPPORTUNITIES
      • 5.1.3.1 High scope of growth in emerging economies
      • 5.1.3.2 Improving regulatory and reimbursement scenario
      • 5.1.3.3 Molecular diagnostics and personalized medicine
    • 5.1.4 TRENDS
      • 5.1.4.1 Impact of the COVID-19 pandemic
      • 5.1.4.2 Increase in government funding

6 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
  • 6.2 KITS
    • 6.2.1 KITS WERE THE LARGEST PRODUCT SEGMENT IN THE MARKET IN 2019
  • 6.3 REAGENTS
    • 6.3.1 REAGENTS SEGMENT TO GROW AT A STEADY RATE DURING THE FORECAST PERIOD
  • 6.4 INSTRUMENTS
    • 6.4.1 AUTOMATED INSTRUMENTS ENABLE A FASTER, CLEANER, AND MORE CONSISTENT NUCLEIC ACID EXTRACTION PROCESS

7 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD

  • 7.1 INTRODUCTION
  • 7.2 COLUMN-BASED ISOLATION AND PURIFICATION
    • 7.2.1 COLUMN-BASED ISOLATION AND PURIFICATION WAS THE LARGEST SEGMENT IN THE MARKET IN 2019
  • 7.3 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION
    • 7.3.1 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • 7.4 REAGENT-BASED ISOLATION AND PURIFICATION
    • 7.4.1 REAGENT-BASED ISOLATION AND PURIFICATION SEGMENT TO REGISTER STEADY GROWTH DURING THE FORECAST PERIOD
  • 7.5 OTHER ISOLATION AND PURIFICATION METHODS

8 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE

  • 8.1 INTRODUCTION
  • 8.2 PLASMID DNA ISOLATION AND PURIFICATION
    • 8.2.1 PLASMID DNA ISOLATION AND PURIFICATION ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET
  • 8.3 TOTAL RNA ISOLATION AND PURIFICATION
    • 8.3.1 TOTAL RNA ISOLATION AND PURIFICATION SEGMENT TO REGISTER STEADY GROWTH
  • 8.4 GENOMIC DNA ISOLATION AND PURIFICATION
    • 8.4.1 GENOMIC DNA ISOLATION IS THE FIRST STEP IN GENETIC-BASED TESTS
  • 8.5 MESSENGER RNA ISOLATION AND PURIFICATION
    • 8.5.1 MESSENGER RNA ISOLATION AND PURIFICATION IS MAINLY USED IN THE STUDY OF GENE EXPRESSION AND TRANSCRIPTOMICS
  • 8.6 CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION
    • 8.6.1 CLINICAL APPLICATIONS TO DRIVE THE MARKET FOR CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION
  • 8.7 MICRORNA ISOLATION AND PURIFICATION
    • 8.7.1 MICRORNA KITS PROVIDE RAPID ISOLATION AND PURIFICATION OF RNA MOLECULES FROM SAMPLES
  • 8.8 PCR CLEANUP
    • 8.8.1 TIME-CONSUMING LABORATORY PROCEDURES TO LIMIT THE GROWTH OF THIS MARKET DURING THE FORECAST PERIOD
  • 8.9 OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES

9 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION

  • 9.1 INTRODUCTION
  • 9.2 DIAGNOSTICS
    • 9.2.1 DIAGNOSTIC APPLICATIONS FORM THE LARGEST AND FASTEST-GROWING SEGMENT IN THE MARKET
  • 9.3 DRUG DISCOVERY & DEVELOPMENT
    • 9.3.1 NGS BENEFITS DRUG DISCOVERY APPLICATIONS IN VARIOUS THERAPEUTIC AREAS
  • 9.4 PERSONALIZED MEDICINE
    • 9.4.1 RISING INCIDENCE OF CANCER AND INCREASING RESEARCH AND FUNDING TO DRIVE THE MARKET FOR THIS SEGMENT
  • 9.5 AGRICULTURE & ANIMAL RESEARCH
    • 9.5.1 FAVORABLE FUNDING SCENARIO TO SUPPORT MARKET GROWTH
  • 9.6 OTHER APPLICATIONS

10 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER

  • 10.1 INTRODUCTION
  • 10.2 HOSPITALS & DIAGNOSTIC CENTERS
    • 10.2.1 AVAILABILITY OF GENETIC TESTS AND RISING FOCUS ON PERSONALIZED MEDICINE IN HOSPITALS TO DRIVE MARKET GROWTH
  • 10.3 ACADEMIC & GOVERNMENT RESEARCH INSTITUTES
    • 10.3.1 INCREASE IN RESEARCH INTENSITY TO DRIVE THE USAGE OF NUCLEIC ACID ISOLATION AND PURIFICATION SYSTEMS
  • 10.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 10.4.1 INCREASING NUMBER OF RESEARCH PROJECTS IN GENOMICS AND RELATED AREAS IS EXPECTED TO DRIVE THE MARKET
  • 10.5 CONTRACT RESEARCH ORGANIZATIONS
    • 10.5.1 CONTRACT RESEARCH ORGANIZATIONS ARE EXPECTED TO REGISTER STEADY GROWTH DURING THE FORECAST PERIOD
  • 10.6 OTHER END USERS

11 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION

  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    • 11.2.1 US
      • 11.2.1.1 Government and private funding to support market growth in the US
    • 11.2.2 CANADA
      • 11.2.2.1 Demand for nucleic acid isolation and purification in Canada is increasing primarily due to growing investments in genomics
  • 11.3 EUROPE
    • 11.3.1 GERMANY
      • 11.3.1.1 Germany is the largest market for nucleic acid isolation and purification in Europe
    • 11.3.2 UK
      • 11.3.2.1 Government support for research in the form of investments, funds, and grants to support market growth
    • 11.3.3 FRANCE
      • 11.3.3.1 High cancer burden in France to drive market growth
    • 11.3.4 ROE
  • 11.4 ASIA PACIFIC
    • 11.4.1 CHINA
      • 11.4.1.1 China to register the highest growth in the nucleic acid isolation and purification market in APAC
    • 11.4.2 JAPAN
      • 11.4.2.1 Japan to register steady growth during the forecast period
    • 11.4.3 INDIA
      • 11.4.3.1 Strong growth trends in the pharmaceutical & biotechnology industries to drive the market in India
    • 11.4.4 ROAPAC
  • 11.5 REST OF THE WORLD
    • 11.5.1 LATIN AMERICA
      • 11.5.1.1 To prevent cancer mortality, the Brazilian government recommends screening programs for breast and prostate cancer
    • 11.5.2 MIDDLE EAST & AFRICA
      • 11.5.2.1 Lack of infrastructure for research to hamper the growth of the NAIP market in the Middle East & Africa

12 COMPETITIVE LANDSCAPE

  • 12.1 INTRODUCTION
  • 12.2 MARKET EVALUATION FRAMEWORK
  • 12.3 REVENUE ANALYSIS OF TOP MARKET PLAYERS
  • 12.4 COMPETITIVE SCENARIO
    • 12.4.1 COLLABORATIONS & AGREEMENTS
    • 12.4.2 PRODUCT LAUNCHES & APPROVALS
    • 12.4.3 ACQUISITIONS
    • 12.4.4 EXPANSIONS

13 COMPANY EVALUATION MATRIX AND COMPANY PROFILES

  • 13.1 COMPANY EVALUATION MATRIX
    • 13.1.1 MARKET SHARE ANALYSIS
  • 13.2 COMPETITIVE LEADERSHIP MAPPING (OVERALL MARKET) (2019)
    • 13.2.1 STARS
    • 13.2.2 EMERGING LEADERS
    • 13.2.3 PERVASIVE PLAYERS
    • 13.2.4 EMERGING COMPANIES

14 COMPANY PROFILES (Business Overview, Products Offered, Recent Developments, MnM View)*

  • 14.1 QIAGEN N.V.
  • 14.2 THERMO FISHER SCIENTIFIC
  • 14.3 F. HOFFMAN-LA ROCHE AG
  • 14.4 PROMEGA CORPORATION
  • 14.5 AGILENT TECHNOLOGIES
  • 14.6 BIO-RAD LABORATORIES
  • 14.7 DANAHER CORPORATION
  • 14.8 GE HEALTHCARE
  • 14.9 ILLUMINA
  • 14.10 MERCK KGAA
  • 14.11 TAKARA BIO, INC.
  • 14.12 NEW ENGLAND BIOLABS
  • 14.13 ZYMO RESEARCH
  • 14.14 NORGEN BIOTEK
  • 14.15 OMEGA BIO-TEK, INC.
  • 14.16 OTHER COMPANIES
    • 14.16.1 GENAXXON BIOSCIENCE GMBH
    • 14.16.2 3B BLACKBIO BIOTECH INDIA LTD.
    • 14.16.3 INVITEK MOLECULAR GMBH
    • 14.16.4 BIOVISION
    • 14.16.5 ANALYTIK JENA AG

Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

15 APPENDIX

  • 15.1 DISCUSSION GUIDE
  • 15.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 15.3 AVAILABLE CUSTOMIZATIONS
  • 15.4 RELATED REPORTS
  • 15.5 AUTHOR DETAILS